Press Release

Hetero Enters Into a Licensing Agreement With Gilead Sciences, Inc. for the Manufacturing and Distribution of “Remdesivir” in 127 Countries, Including India, for COVID-19

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *